First Eagle Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-35,412
Closed -$1.9M 250
2017
Q4
$1.9M Buy
35,412
+6,288
+22% +$349K ﹤0.01% 203
2017
Q3
$1.78M Buy
29,124
+20,960
+257% +$1.27M ﹤0.01% 211
2017
Q2
$499K Hold
8,164
﹤0.01% 239
2017
Q1
$495K Hold
8,164
﹤0.01% 235
2016
Q4
$459K Hold
8,164
﹤0.01% 236
2016
Q3
$486K Hold
8,164
﹤0.01% 261
2016
Q2
$449K Sell
8,164
-8,698
-52% -$463K ﹤0.01% 271
2016
Q1
$851K Buy
16,862
+8,698
+107% +$426K ﹤0.01% 241
2015
Q4
$411K Sell
8,164
-1,320
-14% -$66.6K ﹤0.01% 249
2015
Q3
$447K Hold
9,484
﹤0.01% 246
2015
Q2
$515K Hold
9,484
﹤0.01% 238
2015
Q1
$520K Hold
9,484
﹤0.01% 248
2014
Q4
$514K Sell
9,484
-1,126,366
-99% -$62.8M ﹤0.01% 252
2014
Q3
$64.2M Sell
1,135,850
-703,476
-38% -$39.5M 0.16% 110
2014
Q2
$102M Sell
1,839,326
-504,881
-22% -$27.5M 0.25% 86
2014
Q1
$127M Buy
2,344,207
+2,329,483
+15,821% +$121M 0.34% 80
2013
Q4
$703K Sell
14,724
-1,173,751
-99% -$53.7M ﹤0.01% 225
2013
Q3
$54M Sell
1,188,475
-1,169,825
-50% -$53.4M 0.16% 108
2013
Q2
$105M Buy
+2,358,300
New +$105M 0.32% 73

Other funds holding MRK

First Eagle Investment Management's MRK Position: Q1 2018 in Review

First Eagle Investment Management sold out of Merck (MRK) in Q1 2018, closing a stake of 35,412 shares — an estimated $1.9M sold.

First Eagle Investment Management first reported a position in MRK in Q2 2013 and held it in 19 quarters. The position peaked at $127M in Q1 2014. 1,993 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

  • First Eagle Investment Management reported no remaining Merck position as of Q1 2018 after selling out during the quarter.
  • First Eagle Investment Management sold 35,412 Merck shares in Q1 2018, an estimated $1.9M.
  • First Eagle Investment Management first reported a position in Merck in Q2 2013 and held it in 19 quarters.
  • First Eagle Investment Management's Merck position peaked at $127M in Q1 2014.
  • 1,993 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on First Eagle Investment Management's 13F filing for Q1 2018, filed 4 May 2018.